Pathways

Haematology-Oncology: LYMPHOMAS (part 1)

Start the pathway
0% COMPLETED
Part of a Pathway
Start e-Session
New treatment options in CLL
J. Khader
Part of a Pathway
Start e-Session
FL chemo or chemo-free? (Lymphoma 2019)
E. Zucca
Part of a Pathway
Start e-Session
Main Indolent Entities: WM (Lymphoma 2019)
G. Merlini
Part of a Pathway
Start e-Session
High-Grade B-Cell NHL and BL (Lymphoma 2019)
L. Sehn
Part of a Pathway
Start e-Session
Mantle cell lymphoma (Lymphoma 2019)
S. Rule
Part of a Pathway
Start e-Session
Primary and secondary CNS involvement (Lymphoma 2019)
T. Batchelor
Part of a Pathway
Start e-Session
1st line treatment in HL
A. Pavlovsky
Part of a Pathway
Start e-Session
CAR-T Cell Therapy: Where do we stand (Lymphoma 2019)
S. Neelapu
Part of a Pathway
Start e-Session
Liquid biopsy in lymphoma
D. Rossi
Part of a Pathway
Start Podcast
Breast implant associated anaplastic large cell lymphoma
N. Rocco
ESCO logo
ESCO is the College of the European School of Oncology for ESO students offering a structured educational pathway to enhance their oncology careers.
Ulm university
Ulm university
The e-ESO e-Sessions are part of the Master-Online Study Program Advanced Oncology of Ulm University
www.uni-ulm.de
The mastermind winners of
e-Session 660
  1. Reda Mohamed Husseen
  2. Marina Puchinskaya
  3. Zacharoula Sidiropoulou
ESO & OncoAlert
e-Eso Onco alert
Oncology education together via social media
facebook eso twitter eso instagram eso